News provided by University of Colorado Anschutz Jul 29, 2026, 00:00 ET A study from the University of Colorado Anschutz found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder (AUD)
This unique NSAID-antagonizing effect presents a significant potential clinical application for patients requiring long-term NSAID therapy
Get your customized calorie and protein needs
Please contact your doctor if you have any questions or concerns regarding your health
You need alcohol wipes, the syringe or pen, a sharps disposal container, and optionally a bandage